US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Replimune Group Inc.

9.66

+0.05000.52%

Post-market: 9.47-0.1900-1.97%17:49 EST

Volume:1.13M

Turnover:10.85M

Market Cap:757.76M

PE:-2.79

High:9.82

Open:9.60

Low:9.50

Close:9.61

52wk High:14.80

52wk Low:2.68

Shares:78.44M

Float Shares:49.97M

Volume Ratio:0.69

T/O Rate:2.25%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.4678

EPS(LYR):-3.0696

ROE:-96.24%

ROA:-44.83%

PB:2.88

PE(LYR):-3.15

Loading ...

Overview Company News Filings

Gold Falls Over 1%; Darden Posts Downbeat Earnings

Replimune Says Path Forward Not Determined for RP1 in Advanced Melanoma

MT Newswires Live

Replimune Shares Fall as Regulatory Uncertainty Looms For Melanoma Drug

Replimune Group Inc - Evaluating FDA Feedback, Path Forward Undetermined

THOMSON REUTERS

Replimune Provides Update Following Type a Meeting With FDA

THOMSON REUTERS

Press Release: Replimune Provides Update Following Type A Meeting with FDA

Replimune Group Inc. Faces Class Action Lawsuit for Alleged Securities Fraud: Investors Urged to Take Action

Replimune Group Inc. Schedules FDA Meeting to Address CRL for RP1 in Advanced Melanoma Treatment

Replimune Announces Type a Meeting Scheduled With FDA

THOMSON REUTERS

Replimune Group- Briefing Book Includes Additional Analysis of Data From Bla & Addresses Comments About Phase 3 Confirmatory Trial Design

THOMSON REUTERS

Replimune Group Inc - Submits Briefing Book to FDA Addressing Crl

THOMSON REUTERS

Replimune Group Inc - Meeting to Discuss Crl for Rp1 Bla With Nivolumab for Melanoma

THOMSON REUTERS

Replimune Group Inc. Faces Class Action Lawsuit Over Alleged Securities Fraud

CFO Emily Luisa Hill Reports Disposal of Replimune Group Inc. Common Shares

Gene Therapy Developers Fall After Vinay Prasad Reinstated As FDA's Top Vaccine Official

Replimune Group Inc reports results for the quarter ended June 30 - Earnings Summary

Replimune Group Q1 EPS $(0.95) Misses $(0.84) Estimate

Replimune Group Q1 Net Income USD -86.693 Million

Replimune Group Q1 Operating Income USD -90.422 Million

THOMSON REUTERS

Replimune Group Q1 Cash & Investments USD 403.3 Million

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/REPL/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"REPL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REPL\",,,,,undefined,":{"symbol":"REPL","market":"US","secType":"STK","nameCN":"Replimune Group Inc.","latestPrice":9.66,"timestamp":1766005200000,"preClose":9.61,"halted":0,"volume":1125084,"hourTrading":{"tag":"盘后","latestPrice":9.47,"preClose":9.66,"latestTime":"17:49 EST","volume":71498,"amount":690573.7,"timestamp":1766011776387},"delay":0,"floatShares":49968589,"shares":78443334,"eps":-3.467754,"marketStatus":"Not Yet Opened","change":0.05,"latestTime":"12-17 16:00:00 EST","open":9.6,"high":9.82,"low":9.495,"amount":10846271.04444,"amplitude":0.033819,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.467754,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1766048400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1532059200000,"exchange":"NASDAQ","adjPreClose":9.61,"preHourTrading":{"tag":"盘前","latestPrice":9.66,"preClose":9.61,"latestTime":"08:00 EST","volume":501,"amount":4830.579876,"timestamp":1765976401243},"postHourTrading":{"tag":"盘后","latestPrice":9.47,"preClose":9.66,"latestTime":"17:49 EST","volume":71498,"amount":690573.7,"timestamp":1766011776387},"volumeRatio":0.690341,"impliedVol":0.7944,"impliedVolPercentile":0.2731},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REPL\",,,,,undefined,":{"symbol":"REPL","floatShares":49968589,"roa":"-44.83%","roe":"-96.24%","lyrEps":-3.069566,"volumeRatio":0.690341,"shares":78443334,"dividePrice":0,"high":9.82,"amplitude":0.033819,"preClose":9.61,"low":9.495,"week52Low":2.68,"pbRate":"2.88","week52High":14.7952,"institutionHeld":0,"latestPrice":9.66,"eps":-3.467754,"divideRate":0,"volume":1125084,"delay":0,"ttmEps":-3.467754,"open":9.6,"prevYearClose":12.11,"prevWeekClose":10.18,"prevMonthClose":10,"prevQuarterClose":4.19,"fiveDayClose":9.82,"twentyDayClose":8.74,"sixtyDayClose":4.33},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/REPL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-06","symbol":"REPL","fiscalQuarterEnding":"2025/09","expectedEps":-0.87,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.9},{"market":"US","date":"2025-08-07","symbol":"REPL","fiscalQuarterEnding":"2025/06","expectedEps":-0.83,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":-0.95},{"market":"US","date":"2025-05-22","symbol":"REPL","fiscalQuarterEnding":"2025/03","expectedEps":-0.75,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747886400000,"reportTimeType":"pre","actualEps":-0.82},{"market":"US","date":"2025-02-12","symbol":"REPL","fiscalQuarterEnding":"2024/12","expectedEps":-0.7,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739336400000,"reportTimeType":"pre","actualEps":-0.79},{"market":"US","date":"2024-11-12","symbol":"REPL","fiscalQuarterEnding":"2024/09","expectedEps":-0.75,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.68}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"REPL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"REPL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.375,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.375,"analysts":8,"updateTime":1762059600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/REPL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"REPL","date":"2025-12-16","current":-2.785665,"percent":0.824167,"low":-30.108202,"twenty":-13.709401,"median":-6.368208,"eighty":-2.601554,"high":-0.874367,"avg":-8.118652,"sd":6.692467,"marketCap":780511173},"quantilePoints":[{"date":"2020-12-18","current":-26.335592,"twenty":-17.792762,"median":-15.443392,"eighty":-12.942942,"marketCap":1832061822},{"date":"2020-12-24","current":-27.656997,"twenty":-17.833312,"median":-15.458438,"eighty":-12.956155,"marketCap":1923986650},{"date":"2020-12-31","current":-25.205792,"twenty":-17.920221,"median":-15.494801,"eighty":-12.966751,"marketCap":1753466094},{"date":"2021-01-08","current":-28.264843,"twenty":-18.079218,"median":-15.510137,"eighty":-12.974293,"marketCap":1966272070},{"date":"2021-01-15","current":-28.562159,"twenty":-18.261285,"median":-15.518256,"eighty":-12.984598,"marketCap":1986955157},{"date":"2021-01-22","current":-29.288932,"twenty":-18.635844,"median":-15.526131,"eighty":-12.991308,"marketCap":2037513812},{"date":"2021-01-29","current":-25.635248,"twenty":-18.853106,"median":-15.53104,"eighty":-12.994069,"marketCap":1783341663},{"date":"2021-02-05","current":-26.84076,"twenty":-19.504667,"median":-15.567438,"eighty":-13.012644,"marketCap":2017351533},{"date":"2021-02-12","current":-22.819904,"twenty":-21.940848,"median":-15.587711,"eighty":-13.047473,"marketCap":1715143997},{"date":"2021-02-19","current":-23.457055,"twenty":-22.436376,"median":-15.606138,"eighty":-13.066316,"marketCap":1763032268},{"date":"2021-02-26","current":-21.421883,"twenty":-22.436376,"median":-15.622317,"eighty":-13.072547,"marketCap":1610068762},{"date":"2021-03-05","current":-21.842527,"twenty":-22.250798,"median":-15.636738,"eighty":-13.086716,"marketCap":1641684319},{"date":"2021-03-12","current":-21.025984,"twenty":-22.237184,"median":-15.656023,"eighty":-13.114651,"marketCap":1580312943},{"date":"2021-03-19","current":-21.8982,"twenty":-22.080584,"median":-15.667314,"eighty":-13.127516,"marketCap":1645868731},{"date":"2021-03-26","current":-20.512551,"twenty":-22.071406,"median":-15.706391,"eighty":-13.135191,"marketCap":1541723365},{"date":"2021-04-01","current":-19.535174,"twenty":-21.972742,"median":-15.742909,"eighty":-13.178949,"marketCap":1468263687},{"date":"2021-04-09","current":-18.601098,"twenty":-21.919166,"median":-15.779654,"eighty":-13.197111,"marketCap":1398058552},{"date":"2021-04-16","current":-18.533053,"twenty":-21.910845,"median":-15.805723,"eighty":-13.201843,"marketCap":1392944271},{"date":"2021-04-23","current":-19.491873,"twenty":-21.900674,"median":-15.81014,"eighty":-13.203144,"marketCap":1465009145},{"date":"2021-04-30","current":-22.634326,"twenty":-21.910845,"median":-15.823722,"eighty":-13.207951,"marketCap":1701195957},{"date":"2021-05-07","current":-22.170381,"twenty":-21.950473,"median":-15.85094,"eighty":-13.241757,"marketCap":1666325857},{"date":"2021-05-14","current":-21.681693,"twenty":-21.982329,"median":-15.875459,"eighty":-13.250591,"marketCap":1629596018},{"date":"2021-05-21","current":-20.875188,"twenty":-21.982329,"median":-15.901941,"eighty":-13.258245,"marketCap":1688176458},{"date":"2021-05-28","current":-22.460135,"twenty":-22.073242,"median":-15.955897,"eighty":-13.283002,"marketCap":1816351093},{"date":"2021-06-04","current":-18.443015,"twenty":-22.004598,"median":-16.002994,"eighty":-13.28992,"marketCap":1491486656},{"date":"2021-06-11","current":-19.595704,"twenty":-21.95287,"median":-16.012966,"eighty":-13.290718,"marketCap":1584704572},{"date":"2021-06-18","current":-20.402586,"twenty":-21.932997,"median":-16.057318,"eighty":-13.292929,"marketCap":1649957113},{"date":"2021-06-25","current":-22.425554,"twenty":-21.932997,"median":-16.081436,"eighty":-13.298312,"marketCap":1813554555},{"date":"2021-07-02","current":-22.788651,"twenty":-22.105608,"median":-16.100527,"eighty":-13.307038,"marketCap":1842918199},{"date":"2021-07-09","current":-20.212392,"twenty":-22.076913,"median":-16.114408,"eighty":-13.311118,"marketCap":1634576157},{"date":"2021-07-16","current":-18.039574,"twenty":-22.026868,"median":-16.132614,"eighty":-13.319278,"marketCap":1458860385},{"date":"2021-07-23","current":-19.063158,"twenty":-21.955266,"median":-16.139958,"eighty":-13.347051,"marketCap":1541637578},{"date":"2021-07-30","current":-18.912918,"twenty":-21.938023,"median":-16.15228,"eighty":-13.375517,"marketCap":1529487661},{"date":"2021-08-06","current":-16.792794,"twenty":-21.918542,"median":-16.19167,"eighty":-13.387047,"marketCap":1522904883},{"date":"2021-08-13","current":-15.575626,"twenty":-21.911392,"median":-16.205733,"eighty":-13.404574,"marketCap":1412522342},{"date":"2021-08-20","current":-15.560153,"twenty":-21.905623,"median":-16.15308,"eighty":-13.425364,"marketCap":1411119174},{"date":"2021-08-27","current":-16.22547,"twenty":-21.895726,"median":-16.15228,"eighty":-13.431331,"marketCap":1471455393},{"date":"2021-09-03","current":-16.988778,"twenty":-21.874892,"median":-16.19167,"eighty":-13.433519,"marketCap":1540678343},{"date":"2021-09-10","current":-16.514289,"twenty":-21.847873,"median":-16.210444,"eighty":-13.441423,"marketCap":1497647861},{"date":"2021-09-17","current":-16.803109,"twenty":-21.82081,"median":-16.215155,"eighty":-13.475095,"marketCap":1523840328},{"date":"2021-09-24","current":-16.638069,"twenty":-21.723491,"median":-16.238363,"eighty":-13.488815,"marketCap":1508873204},{"date":"2021-10-01","current":-15.240389,"twenty":-21.67427,"median":-16.219027,"eighty":-13.513752,"marketCap":1382120371},{"date":"2021-10-08","current":-15.972753,"twenty":-21.626019,"median":-16.19167,"eighty":-13.533427,"marketCap":1448536985},{"date":"2021-10-15","current":-15.549838,"twenty":-21.540653,"median":-16.15388,"eighty":-13.565594,"marketCap":1410183729},{"date":"2021-10-22","current":-14.961884,"twenty":-21.492962,"median":-16.14312,"eighty":-13.567208,"marketCap":1356863349},{"date":"2021-10-29","current":-15.219759,"twenty":-21.476079,"median":-16.139261,"eighty":-13.574656,"marketCap":1380249481},{"date":"2021-11-05","current":-15.694027,"twenty":-21.451576,"median":-16.135948,"eighty":-13.594071,"marketCap":1568586638},{"date":"2021-11-12","current":-15.689335,"twenty":-21.392191,"median":-16.126343,"eighty":-13.624185,"marketCap":1568117703},{"date":"2021-11-19","current":-16.06937,"twenty":-21.266207,"median":-16.114408,"eighty":-13.633329,"marketCap":1606101416},{"date":"2021-11-26","current":-13.606182,"twenty":-21.237353,"median":-16.104262,"eighty":-13.632281,"marketCap":1359910688},{"date":"2021-12-03","current":-12.977483,"twenty":-21.223934,"median":-16.091557,"eighty":-13.587048,"marketCap":1297073435},{"date":"2021-12-10","current":-12.907106,"twenty":-21.205376,"median":-16.076662,"eighty":-13.56612,"marketCap":1290039414},{"date":"2021-12-17","current":-12.311249,"twenty":-21.124959,"median":-16.069894,"eighty":-13.48331,"marketCap":1230484705},{"date":"2021-12-23","current":-13.517038,"twenty":-21.122485,"median":-16.044742,"eighty":-13.433519,"marketCap":1351000928},{"date":"2021-12-31","current":-12.714743,"twenty":-21.069904,"median":-16.015764,"eighty":-13.41643,"marketCap":1270813091},{"date":"2022-01-07","current":-12.189262,"twenty":-21.03217,"median":-16.010593,"eighty":-13.380684,"marketCap":1218292402},{"date":"2022-01-14","current":-11.199295,"twenty":-21.025984,"median":-15.986212,"eighty":-13.311118,"marketCap":1119347176},{"date":"2022-01-21","current":-9.74015,"twenty":-21.006293,"median":-15.955897,"eighty":-13.293375,"marketCap":973508478},{"date":"2022-01-28","current":-8.731415,"twenty":-20.94976,"median":-15.905705,"eighty":-13.286213,"marketCap":872687513},{"date":"2022-02-04","current":-7.99328,"twenty":-20.910732,"median":-15.895098,"eighty":-13.233597,"marketCap":861987330},{"date":"2022-02-11","current":-7.673724,"twenty":-20.897089,"median":-15.869823,"eighty":-13.195305,"marketCap":827526719},{"date":"2022-02-18","current":-7.047744,"twenty":-20.882104,"median":-15.845206,"eighty":-13.132121,"marketCap":760021687},{"date":"2022-02-25","current":-7.183446,"twenty":-20.847524,"median":-15.829866,"eighty":-13.09789,"marketCap":774655645},{"date":"2022-03-04","current":-6.728188,"twenty":-20.805093,"median":-15.823685,"eighty":-13.048554,"marketCap":725561076},{"date":"2022-03-11","current":-7.157181,"twenty":-20.790794,"median":-15.81014,"eighty":-12.996831,"marketCap":771823266},{"date":"2022-03-18","current":-7.179069,"twenty":-20.744594,"median":-15.804542,"eighty":-12.973236,"marketCap":774183582},{"date":"2022-03-25","current":-6.999592,"twenty":-20.701197,"median":-15.776661,"eighty":-12.940996,"marketCap":754828992},{"date":"2022-04-01","current":-7.99328,"twenty":-20.631971,"median":-15.738739,"eighty":-12.832728,"marketCap":861987330},{"date":"2022-04-08","current":-8.5142,"twenty":-20.531056,"median":-15.706391,"eighty":-12.758307,"marketCap":918162846},{"date":"2022-04-14","current":-7.774406,"twenty":-20.522449,"median":-15.696716,"eighty":-12.748252,"marketCap":838384172},{"date":"2022-04-22","current":-8.01079,"twenty":-20.493993,"median":-15.689335,"eighty":-12.730018,"marketCap":863875582},{"date":"2022-04-29","current":-7.341035,"twenty":-20.416327,"median":-15.662226,"eighty":-12.654887,"marketCap":791649919},{"date":"2022-05-06","current":-6.452407,"twenty":-20.38299,"median":-15.655671,"eighty":-12.538835,"marketCap":695821097},{"date":"2022-05-13","current":-6.491804,"twenty":-20.292997,"median":-15.6402,"eighty":-12.449348,"marketCap":700069666},{"date":"2022-05-20","current":-6.148507,"twenty":-20.245319,"median":-15.637726,"eighty":-12.395603,"marketCap":725745226},{"date":"2022-05-27","current":-6.235809,"twenty":-20.234774,"median":-15.631638,"eighty":-12.379449,"marketCap":736049925},{"date":"2022-06-03","current":-6.809503,"twenty":-20.212392,"median":-15.622317,"eighty":-12.311955,"marketCap":803766518},{"date":"2022-06-10","current":-6.468612,"twenty":-20.203255,"median":-15.607654,"eighty":-12.134279,"marketCap":763529122},{"date":"2022-06-17","current":-6.318953,"twenty":-20.189959,"median":-15.595469,"eighty":-11.992537,"marketCap":745863924},{"date":"2022-06-24","current":-7.699145,"twenty":-20.143355,"median":-15.58377,"eighty":-11.944204,"marketCap":908776307},{"date":"2022-07-01","current":-7.640944,"twenty":-20.124611,"median":-15.580646,"eighty":-11.881776,"marketCap":901906508},{"date":"2022-07-08","current":-8.79249,"twenty":-20.103951,"median":-15.560153,"eighty":-11.848266,"marketCap":1037830394},{"date":"2022-07-15","current":-8.534744,"twenty":-20.061997,"median":-15.550705,"eighty":-11.726024,"marketCap":1007406997},{"date":"2022-07-22","current":-7.782289,"twenty":-20.016455,"median":-15.527958,"eighty":-11.633525,"marketCap":918590306},{"date":"2022-07-29","current":-8.053709,"twenty":-19.98877,"median":-15.522807,"eighty":-11.543915,"marketCap":950627642},{"date":"2022-08-05","current":-7.601167,"twenty":-19.981078,"median":-15.512904,"eighty":-11.450611,"marketCap":1010788047},{"date":"2022-08-12","current":-7.515886,"twenty":-19.970963,"median":-15.503521,"eighty":-11.34073,"marketCap":999447498},{"date":"2022-08-19","current":-7.145097,"twenty":-19.933441,"median":-15.494489,"eighty":-11.242484,"marketCap":950140764},{"date":"2022-08-26","current":-7.108019,"twenty":-19.888487,"median":-15.449739,"eighty":-11.188671,"marketCap":945210090},{"date":"2022-09-02","current":-6.993074,"twenty":-19.816752,"median":-15.442937,"eighty":-10.953866,"marketCap":929925003},{"date":"2022-09-09","current":-6.80768,"twenty":-19.756813,"median":-15.436976,"eighty":-10.890541,"marketCap":905271636},{"date":"2022-09-16","current":-6.110597,"twenty":-19.689634,"median":-15.431329,"eighty":-10.778331,"marketCap":812574976},{"date":"2022-09-23","current":-5.888124,"twenty":-19.622483,"median":-15.403136,"eighty":-10.685646,"marketCap":782990935},{"date":"2022-09-30","current":-6.40352,"twenty":-19.571492,"median":-15.3916,"eighty":-10.533097,"marketCap":851527296},{"date":"2022-10-07","current":-6.407228,"twenty":-19.534008,"median":-15.373891,"eighty":-10.386415,"marketCap":852020363},{"date":"2022-10-14","current":-6.918916,"twenty":-19.530951,"median":-15.351275,"eighty":-10.014098,"marketCap":920063656},{"date":"2022-10-21","current":-7.104311,"twenty":-19.514142,"median":-15.301721,"eighty":-9.807604,"marketCap":944717023},{"date":"2022-10-28","current":-6.700151,"twenty":-19.463693,"median":-15.295377,"eighty":-9.668193,"marketCap":890972683},{"date":"2022-11-04","current":-6.285013,"twenty":-19.412753,"median":-15.286558,"eighty":-9.346952,"marketCap":922168605},{"date":"2022-11-11","current":-7.118947,"twenty":-19.397565,"median":-15.277234,"eighty":-9.233032,"marketCap":1044527547},{"date":"2022-11-18","current":-6.451122,"twenty":-19.391261,"median":-15.249135,"eighty":-9.01396,"marketCap":946540915},{"date":"2022-11-25","current":-6.77656,"twenty":-19.371343,"median":-15.242339,"eighty":-8.798362,"marketCap":994290745},{"date":"2022-12-02","current":-6.888429,"twenty":-19.304205,"median":-15.235232,"eighty":-8.708895,"marketCap":1010704750},{"date":"2022-12-09","current":-9.390679,"twenty":-19.279831,"median":-15.219759,"eighty":-8.63141,"marketCap":1377847325},{"date":"2022-12-16","current":-10.475589,"twenty":-19.272597,"median":-15.211631,"eighty":-8.66615,"marketCap":1537030766},{"date":"2022-12-23","current":-10.317569,"twenty":-19.263359,"median":-15.167534,"eighty":-8.683543,"marketCap":1513845240},{"date":"2022-12-30","current":-10.483297,"twenty":-19.232063,"median":-15.140954,"eighty":-8.703265,"marketCap":1538161768},{"date":"2023-01-06","current":-9.951424,"twenty":-19.172861,"median":-15.102526,"eighty":-8.725785,"marketCap":1460122678},{"date":"2023-01-13","current":-10.814754,"twenty":-19.157758,"median":-15.094278,"eighty":-8.739746,"marketCap":1586794823},{"date":"2023-01-20","current":-10.571943,"twenty":-19.139105,"median":-15.069399,"eighty":-8.744456,"marketCap":1551168282},{"date":"2023-01-27","current":-9.978403,"twenty":-19.098984,"median":-15.054481,"eighty":-8.773977,"marketCap":1464081182},{"date":"2023-02-03","current":-10.9034,"twenty":-19.078394,"median":-15.010475,"eighty":-8.810107,"marketCap":1599801338},{"date":"2023-02-10","current":-9.011098,"twenty":-19.073536,"median":-14.978305,"eighty":-8.917906,"marketCap":1412408501},{"date":"2023-02-17","current":-8.971338,"twenty":-19.066387,"median":-14.977232,"eighty":-8.826962,"marketCap":1406176454},{"date":"2023-02-24","current":-7.156829,"twenty":-19.047944,"median":-14.961884,"eighty":-8.755293,"marketCap":1121768485},{"date":"2023-03-03","current":-7.96649,"twenty":-18.994109,"median":-14.946412,"eighty":-8.688473,"marketCap":1248675626},{"date":"2023-03-10","current":-6.741154,"twenty":-18.947558,"median":-14.924413,"eighty":-8.617499,"marketCap":1056615265},{"date":"2023-03-17","current":-7.084537,"twenty":-18.937613,"median":-14.892132,"eighty":-8.574334,"marketCap":1110437490},{"date":"2023-03-24","current":-7.1496,"twenty":-18.918827,"median":-14.820632,"eighty":-8.464903,"marketCap":1120635385},{"date":"2023-03-31","current":-6.383313,"twenty":-18.90696,"median":-14.796136,"eighty":-8.404346,"marketCap":1000526840},{"date":"2023-04-06","current":-5.967638,"twenty":-18.893903,"median":-14.769731,"eighty":-8.353404,"marketCap":935373620},{"date":"2023-04-14","current":-5.880889,"twenty":-18.876593,"median":-14.754647,"eighty":-8.240934,"marketCap":921776426},{"date":"2023-04-21","current":-6.014628,"twenty":-18.872042,"median":-14.72342,"eighty":-8.237923,"marketCap":942738767},{"date":"2023-04-28","current":-6.058002,"twenty":-18.865271,"median":-14.673543,"eighty":-8.162132,"marketCap":949537364},{"date":"2023-05-05","current":-6.307407,"twenty":-18.84001,"median":-14.642657,"eighty":-8.111975,"marketCap":988629296},{"date":"2023-05-12","current":-6.773685,"twenty":-18.786092,"median":-14.624593,"eighty":-8.085208,"marketCap":1061714212},{"date":"2023-05-18","current":-6.338918,"twenty":-18.760756,"median":-14.598129,"eighty":-8.043545,"marketCap":1104771993},{"date":"2023-05-26","current":-6.368208,"twenty":-18.750284,"median":-14.595028,"eighty":-8.000284,"marketCap":1109876825},{"date":"2023-06-02","current":-6.12621,"twenty":-18.73441,"median":-14.58914,"eighty":-7.976597,"marketCap":1067700350},{"date":"2023-06-09","current":-7.47875,"twenty":-18.702219,"median":-14.527689,"eighty":-7.936373,"marketCap":1303426402},{"date":"2023-06-16","current":-7.962747,"twenty":-18.69597,"median":-14.518235,"eighty":-7.928773,"marketCap":1387779351},{"date":"2023-06-23","current":-7.796994,"twenty":-18.685243,"median":-14.453528,"eighty":-7.888232,"marketCap":1358891355},{"date":"2023-06-30","current":-7.661077,"twenty":-18.667244,"median":-14.399755,"eighty":-7.855942,"marketCap":1335203198},{"date":"2023-07-07","current":-7.004698,"twenty":-18.652142,"median":-14.394793,"eighty":-7.843896,"marketCap":1220806732},{"date":"2023-07-14","current":-6.78922,"twenty":-18.6103,"median":-14.376721,"eighty":-7.822971,"marketCap":1183252336},{"date":"2023-07-21","current":-6.80248,"twenty":-18.564048,"median":-14.344533,"eighty":-7.779136,"marketCap":1185563376},{"date":"2023-07-28","current":-6.594113,"twenty":-18.408435,"median":-14.24963,"eighty":-7.705572,"marketCap":1149248430},{"date":"2023-08-04","current":-6.255847,"twenty":-18.227267,"median":-14.198296,"eighty":-7.665176,"marketCap":1135974257},{"date":"2023-08-11","current":-6.335446,"twenty":-18.127797,"median":-14.118082,"eighty":-7.647887,"marketCap":1150428357},{"date":"2023-08-18","current":-6.198991,"twenty":-17.947873,"median":-14.068648,"eighty":-7.573533,"marketCap":1125649900},{"date":"2023-08-25","current":-6.6311,"twenty":-17.81854,"median":-14.004724,"eighty":-7.50913,"marketCap":1204115013},{"date":"2023-09-01","current":-6.634349,"twenty":-17.717437,"median":-13.953723,"eighty":-7.465927,"marketCap":1204704976},{"date":"2023-09-08","current":-6.367936,"twenty":-17.631427,"median":-13.917117,"eighty":-7.434714,"marketCap":1156327989},{"date":"2023-09-15","current":-6.013801,"twenty":-17.579267,"median":-13.810922,"eighty":-7.397943,"marketCap":1092021994},{"date":"2023-09-28","current":-5.393252,"twenty":-17.366758,"median":-13.743606,"eighty":-7.371559,"marketCap":979339011},{"date":"2023-10-06","current":-5.234053,"twenty":-17.358495,"median":-13.711323,"eighty":-7.341615,"marketCap":950430811},{"date":"2023-10-13","current":-4.792197,"twenty":-17.358973,"median":-13.704061,"eighty":-7.315646,"marketCap":870195808},{"date":"2023-10-19","current":-4.649243,"twenty":-17.359211,"median":-13.6531,"eighty":-7.277231,"marketCap":844237425},{"date":"2023-10-23","current":-4.821437,"twenty":-17.35945,"median":-13.643461,"eighty":-7.266629,"marketCap":875505477},{"date":"2023-10-31","current":-4.6265,"twenty":-17.364158,"median":-13.606182,"eighty":-7.244347,"marketCap":840107682},{"date":"2023-11-10","current":-3.415142,"twenty":-17.32282,"median":-13.521228,"eighty":-7.181695,"marketCap":678001257},{"date":"2023-11-17","current":-3.070058,"twenty":-17.327339,"median":-13.433519,"eighty":-7.15697,"marketCap":609492419},{"date":"2023-11-24","current":-3.090882,"twenty":-17.327339,"median":-13.422358,"eighty":-7.134315,"marketCap":613626573},{"date":"2023-12-01","current":-3.325896,"twenty":-17.327339,"median":-13.311118,"eighty":-7.115651,"marketCap":660283454},{"date":"2023-12-08","current":-2.260895,"twenty":-17.32282,"median":-13.291275,"eighty":-7.101345,"marketCap":448851006},{"date":"2023-12-15","current":-2.308493,"twenty":-17.32282,"median":-13.255017,"eighty":-7.080326,"marketCap":458300501},{"date":"2023-12-22","current":-2.290644,"twenty":-17.32282,"median":-13.177521,"eighty":-7.039837,"marketCap":454756941},{"date":"2023-12-29","current":-2.555407,"twenty":-17.327339,"median":-13.141695,"eighty":-7.025096,"marketCap":507319756},{"date":"2024-01-05","current":-2.620854,"twenty":-17.331857,"median":-13.153424,"eighty":-7.015385,"marketCap":520312811},{"date":"2024-01-12","current":-2.620854,"twenty":-17.331857,"median":-13.153424,"eighty":-6.998149,"marketCap":520312811},{"date":"2024-01-19","current":-2.27577,"twenty":-17.336375,"median":-13.165154,"eighty":-6.976101,"marketCap":451803973},{"date":"2024-01-26","current":-2.347166,"twenty":-17.331857,"median":-13.153424,"eighty":-6.953227,"marketCap":465978216},{"date":"2024-02-02","current":-2.338242,"twenty":-17.331857,"median":-13.131353,"eighty":-6.92926,"marketCap":464206435},{"date":"2024-02-09","current":-2.257183,"twenty":-17.331857,"median":-13.069432,"eighty":-6.885152,"marketCap":473913707},{"date":"2024-02-16","current":-2.23964,"twenty":-17.304882,"median":-13.00772,"eighty":-6.857169,"marketCap":470230440},{"date":"2024-02-23","current":-2.324431,"twenty":-17.304882,"median":-12.978804,"eighty":-6.834348,"marketCap":488032898},{"date":"2024-03-01","current":-2.508631,"twenty":-17.29598,"median":-12.943915,"eighty":-6.80768,"marketCap":526707203},{"date":"2024-03-08","current":-2.58465,"twenty":-17.29598,"median":-12.874263,"eighty":-6.789321,"marketCap":542668028},{"date":"2024-03-15","current":-2.58465,"twenty":-17.29598,"median":-12.874263,"eighty":-6.773685,"marketCap":542668028},{"date":"2024-03-22","current":-2.397526,"twenty":-17.29598,"median":-12.760313,"eighty":-6.739451,"marketCap":503379845},{"date":"2024-03-28","current":-2.412145,"twenty":-17.29598,"median":-12.747585,"eighty":-6.71682,"marketCap":506449234},{"date":"2024-04-05","current":-2.146078,"twenty":-17.304882,"median":-12.701477,"eighty":-6.680523,"marketCap":450586349},{"date":"2024-04-12","current":-2.102221,"twenty":-17.261345,"median":-12.582004,"eighty":-6.649243,"marketCap":441378181},{"date":"2024-04-19","current":-2.037897,"twenty":-17.261345,"median":-12.418128,"eighty":-6.619319,"marketCap":427872868},{"date":"2024-04-26","current":-1.798145,"twenty":-17.253415,"median":-12.311955,"eighty":-6.599292,"marketCap":377534883},{"date":"2024-05-03","current":-1.918021,"twenty":-17.253415,"median":-12.073728,"eighty":-6.568396,"marketCap":402703876},{"date":"2024-05-10","current":-1.967726,"twenty":-17.253415,"median":-11.686636,"eighty":-6.523016,"marketCap":413139799},{"date":"2024-05-17","current":-1.912516,"twenty":-17.253415,"median":-11.471468,"eighty":-6.489603,"marketCap":412709505},{"date":"2024-05-24","current":-1.610839,"twenty":-17.253415,"median":-11.245895,"eighty":-6.455856,"marketCap":347609494},{"date":"2024-05-31","current":-1.451463,"twenty":-17.253415,"median":-11.199295,"eighty":-6.429551,"marketCap":313217035},{"date":"2024-06-07","current":-2.02351,"twenty":-17.253415,"median":-11.019024,"eighty":-6.403667,"marketCap":436661396},{"date":"2024-06-14","current":-2.692322,"twenty":-17.261345,"median":-10.931572,"eighty":-6.396942,"marketCap":580986893},{"date":"2024-06-21","current":-2.239807,"twenty":-17.269275,"median":-10.852478,"eighty":-6.368208,"marketCap":483336876},{"date":"2024-06-28","current":-2.424797,"twenty":-17.29598,"median":-10.804126,"eighty":-6.362258,"marketCap":523256694},{"date":"2024-07-05","current":-2.302419,"twenty":-17.29598,"median":-10.763984,"eighty":-6.338722,"marketCap":496848199},{"date":"2024-07-12","current":-2.823238,"twenty":-17.29598,"median":-10.704911,"eighty":-6.326195,"marketCap":609237841},{"date":"2024-07-15","current":-2.948462,"twenty":-17.29598,"median":-10.672408,"eighty":-6.321564,"marketCap":636260487},{"date":"2024-08-02","current":-3.2357,"twenty":-17.360806,"median":-10.556526,"eighty":-6.30697,"marketCap":698244667},{"date":"2024-08-09","current":-2.934568,"twenty":-17.360806,"median":-10.481741,"eighty":-6.280817,"marketCap":645637192},{"date":"2024-08-16","current":-3.198524,"twenty":-17.360806,"median":-10.336007,"eighty":-6.231015,"marketCap":703710378},{"date":"2024-08-23","current":-3.148838,"twenty":-17.360806,"median":-10.221215,"eighty":-6.160784,"marketCap":692778955},{"date":"2024-08-30","current":-3.434531,"twenty":-17.360806,"median":-10.111004,"eighty":-6.142122,"marketCap":755634639},{"date":"2024-09-06","current":-3.328949,"twenty":-17.360806,"median":-10.055486,"eighty":-6.110199,"marketCap":732405365},{"date":"2024-09-13","current":-3.223367,"twenty":-17.360806,"median":-9.951424,"eighty":-6.072015,"marketCap":709176090},{"date":"2024-09-20","current":-3.487322,"twenty":-17.360806,"median":-9.824237,"eighty":-6.050554,"marketCap":767249277},{"date":"2024-09-27","current":-3.456269,"twenty":-17.341038,"median":-9.672861,"eighty":-6.031978,"marketCap":760417137},{"date":"2024-10-04","current":-3.630169,"twenty":-17.341038,"median":-9.390679,"eighty":-5.972448,"marketCap":798677119},{"date":"2024-10-11","current":-3.453163,"twenty":-17.341038,"median":-9.226291,"eighty":-5.909884,"marketCap":759733923},{"date":"2024-10-18","current":-3.512165,"twenty":-17.341038,"median":-9.011098,"eighty":-5.876626,"marketCap":772714988},{"date":"2024-10-25","current":-3.714014,"twenty":-17.341038,"median":-8.90989,"eighty":-5.795064,"marketCap":817123896},{"date":"2024-10-31","current":-3.760594,"twenty":-17.341038,"median":-8.768922,"eighty":-5.525809,"marketCap":827372105},{"date":"2024-11-08","current":-3.791648,"twenty":-17.205109,"median":-8.678585,"eighty":-5.069007,"marketCap":834204245},{"date":"2024-11-15","current":-3.661401,"twenty":-17.192664,"median":-8.604536,"eighty":-4.715521,"marketCap":779958861},{"date":"2024-11-22","current":-3.548989,"twenty":-17.192664,"median":-8.493293,"eighty":-3.820091,"marketCap":756012756},{"date":"2024-11-29","current":-4.522151,"twenty":-17.192664,"median":-8.424021,"eighty":-3.820091,"marketCap":963317611},{"date":"2024-12-06","current":-4.615452,"twenty":-17.192664,"median":-8.333153,"eighty":-3.820091,"marketCap":983192794},{"date":"2024-12-13","current":-4.321902,"twenty":-17.192664,"median":-8.240025,"eighty":-3.820091,"marketCap":920660225},{"date":"2024-12-20","current":-4.24763,"twenty":-17.192664,"median":-8.201035,"eighty":-3.820091,"marketCap":904838732},{"date":"2024-12-27","current":-4.523497,"twenty":-17.192664,"median":-8.13773,"eighty":-3.820091,"marketCap":963604278},{"date":"2025-01-03","current":-4.537396,"twenty":-17.192664,"median":-8.078641,"eighty":-3.820091,"marketCap":966565111},{"date":"2025-01-10","current":-4.1653,"twenty":-17.196713,"median":-8.023922,"eighty":-3.817856,"marketCap":887300616},{"date":"2025-01-17","current":-3.742629,"twenty":-17.078146,"median":-7.988903,"eighty":-3.790414,"marketCap":797262305},{"date":"2025-01-24","current":-4.967292,"twenty":-16.990879,"median":-7.962747,"eighty":-3.774419,"marketCap":1058142538},{"date":"2025-01-31","current":-4.920329,"twenty":-16.953236,"median":-7.899761,"eighty":-3.774419,"marketCap":1048138282},{"date":"2025-02-07","current":-5.079282,"twenty":-16.830086,"median":-7.844848,"eighty":-3.774419,"marketCap":1081998843},{"date":"2025-02-14","current":-4.821817,"twenty":-16.78929,"median":-7.805048,"eighty":-3.774419,"marketCap":1100541220},{"date":"2025-02-21","current":-4.828566,"twenty":-16.78929,"median":-7.774406,"eighty":-3.774419,"marketCap":1102081516},{"date":"2025-02-28","current":-4.263377,"twenty":-16.78929,"median":-7.699145,"eighty":-3.774419,"marketCap":973081757},{"date":"2025-03-07","current":-3.961381,"twenty":-16.791042,"median":-7.658931,"eighty":-3.769362,"marketCap":904153528},{"date":"2025-03-14","current":-4.001872,"twenty":-16.791042,"median":-7.643303,"eighty":-3.761336,"marketCap":913395302},{"date":"2025-03-21","current":-3.914141,"twenty":-16.791042,"median":-7.573195,"eighty":-3.761336,"marketCap":893371459},{"date":"2025-03-28","current":-3.526102,"twenty":-16.791042,"median":-7.503948,"eighty":-3.734509,"marketCap":804804461},{"date":"2025-04-04","current":-2.662291,"twenty":-16.791042,"median":-7.445715,"eighty":-3.714635,"marketCap":607646622},{"date":"2025-04-11","current":-2.334988,"twenty":-16.78929,"median":-7.411075,"eighty":-3.662101,"marketCap":532942284},{"date":"2025-04-17","current":-2.57456,"twenty":-16.78929,"median":-7.377317,"eighty":-3.643832,"marketCap":587622779},{"date":"2025-04-25","current":-3.057079,"twenty":-16.791042,"median":-7.330201,"eighty":-3.582346,"marketCap":697753915},{"date":"2025-05-02","current":-3.252786,"twenty":-16.791042,"median":-7.279839,"eighty":-3.541256,"marketCap":742422488},{"date":"2025-05-09","current":-2.6218,"twenty":-16.791042,"median":-7.234737,"eighty":-3.513106,"marketCap":598404848},{"date":"2025-05-16","current":-2.43959,"twenty":-16.777387,"median":-7.178793,"eighty":-3.476302,"marketCap":556816866},{"date":"2025-05-23","current":-2.730643,"twenty":-16.657668,"median":-7.147348,"eighty":-3.456269,"marketCap":675279930},{"date":"2025-05-30","current":-2.920791,"twenty":-16.652724,"median":-7.131505,"eighty":-3.437637,"marketCap":722302847},{"date":"2025-06-06","current":-3.039244,"twenty":-16.636006,"median":-7.108524,"eighty":-3.417157,"marketCap":751595812},{"date":"2025-06-13","current":-3.081325,"twenty":-16.625774,"median":-7.092688,"eighty":-3.377634,"marketCap":762002523},{"date":"2025-06-20","current":-2.958197,"twenty":-16.627754,"median":-7.067232,"eighty":-3.325896,"marketCap":731553257},{"date":"2025-06-27","current":-2.948846,"twenty":-16.544737,"median":-7.037548,"eighty":-3.285474,"marketCap":729240655},{"date":"2025-07-03","current":-2.930143,"twenty":-16.498817,"median":-7.021479,"eighty":-3.248209,"marketCap":724615450},{"date":"2025-07-11","current":-3.357195,"twenty":-16.442084,"median":-6.999592,"eighty":-3.235625,"marketCap":830224297},{"date":"2025-07-18","current":-3.896466,"twenty":-16.364758,"median":-6.976101,"eighty":-3.235625,"marketCap":963584375},{"date":"2025-07-25","current":-0.966324,"twenty":-16.32862,"median":-6.95293,"eighty":-3.220261,"marketCap":238968925},{"date":"2025-08-01","current":-2.211852,"twenty":-16.32862,"median":-6.926755,"eighty":-3.197708,"marketCap":546984433},{"date":"2025-08-08","current":-1.521613,"twenty":-16.25891,"median":-6.884333,"eighty":-3.189052,"marketCap":426383313},{"date":"2025-08-15","current":-1.490264,"twenty":-16.251257,"median":-6.855232,"eighty":-3.157696,"marketCap":417598776},{"date":"2025-08-22","current":-1.559902,"twenty":-16.251257,"median":-6.81724,"eighty":-3.102781,"marketCap":437112737},{"date":"2025-08-29","current":-1.498621,"twenty":-16.22547,"median":-6.802605,"eighty":-3.090882,"marketCap":419940451},{"date":"2025-09-05","current":-1.618399,"twenty":-16.215929,"median":-6.784969,"eighty":-3.068883,"marketCap":453504465},{"date":"2025-09-12","current":-1.67411,"twenty":-16.132635,"median":-6.773685,"eighty":-3.048595,"marketCap":469115634},{"date":"2025-09-19","current":-0.963797,"twenty":-16.075902,"median":-6.738316,"eighty":-3.021518,"marketCap":270073227},{"date":"2025-09-26","current":-1.128144,"twenty":-16.075902,"median":-6.70973,"eighty":-2.979471,"marketCap":316126176},{"date":"2025-10-03","current":-1.295276,"twenty":-16.070745,"median":-6.676586,"eighty":-2.957539,"marketCap":362959683},{"date":"2025-10-10","current":-1.289705,"twenty":-15.972753,"median":-6.634349,"eighty":-2.934568,"marketCap":361398566},{"date":"2025-10-17","current":-1.300847,"twenty":-15.720035,"median":-6.618272,"eighty":-2.911439,"marketCap":364520800},{"date":"2025-10-24","current":-2.345425,"twenty":-15.642673,"median":-6.590111,"eighty":-2.877151,"marketCap":657230223},{"date":"2025-10-31","current":-2.855179,"twenty":-15.609575,"median":-6.559251,"eighty":-2.844036,"marketCap":800072421},{"date":"2025-11-07","current":-2.138427,"twenty":-15.549838,"median":-6.518465,"eighty":-2.766893,"marketCap":663474691},{"date":"2025-11-14","current":-2.2704,"twenty":-15.403136,"median":-6.4784,"eighty":-2.692322,"marketCap":704421139},{"date":"2025-11-21","current":-2.277985,"twenty":-15.271334,"median":-6.451122,"eighty":-2.648794,"marketCap":706774439},{"date":"2025-11-28","current":-2.561153,"twenty":-15.219759,"median":-6.429475,"eighty":-2.625584,"marketCap":794630973},{"date":"2025-12-05","current":-2.662284,"twenty":-14.946412,"median":-6.40352,"eighty":-2.620854,"marketCap":826008307},{"date":"2025-12-12","current":-2.495417,"twenty":-13.958066,"median":-6.383313,"eighty":-2.604134,"marketCap":774235706},{"date":"2025-12-16","current":-2.515644,"twenty":-13.709401,"median":-6.368208,"eighty":-2.601554,"marketCap":780511173}],"updateTime":1766018311337},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"REPL\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2568048744","title":"Gold Falls Over 1%; Darden Posts Downbeat Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2568048744","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568048744?lang=en_us&edition=fundamental","pubTime":"2025-09-19 00:27","pubTimestamp":1758212876,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/25/09/47745164/gold-falls-over-1-darden-posts-downbeat-earnings","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVIW.SI","BK4575","REPL","APVO","BK4585","LU0154245673.USD","SQQQ","ETNB","LU0321505439.SGD","BK4550","MNQmain","BK4535","BK4504","QLD","LWAY","QID","LU0321505868.SGD","BK4602","BK4533","BK4605","USJW.SI","BK4579","BK4543","BK4534","TQQQ","BK4527","LU0154245756.USD","TSYW.SI","LU0081259029.USD","BCDA","BK4212","BK4612","BK4515",".IXIC","BK4529","BK4554","BK4209","PSQ","USAW.SI","LU2148611432.USD","DRI","NQmain","LU2543165471.USD","BK4139","BK4588","BK4141","BK4512"],"gpt_icon":1},{"id":"2568403375","title":"Replimune Says Path Forward Not Determined for RP1 in Advanced Melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2568403375","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568403375?lang=en_us&edition=fundamental","pubTime":"2025-09-18 21:57","pubTimestamp":1758203860,"startTime":"0","endTime":"0","summary":"Replimune  said Thursday that a path forward for its biologics license application for RP1 plus nivolumab to treat advanced melanoma has not been determined.The company said it recently completed a type A meeting with the US Food and Drug Administration to discuss the regulator's complete response letter for the RP1 combination therapy.Replimune said it is assessing the FDA's feedback during the meeting to decide on next steps, adding that it was committed to working with the FDA in finding a path forward for RP1.The company's shares fell 38% in recent trading Thursday.Price: 3.54, Change: -2.17, Percent Change: -38.00","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","FORD","BK4145","BK4202","REPL"],"gpt_icon":0},{"id":"2568408098","title":"Replimune Shares Fall as Regulatory Uncertainty Looms For Melanoma Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2568408098","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568408098?lang=en_us&edition=fundamental","pubTime":"2025-09-18 21:43","pubTimestamp":1758202980,"startTime":"0","endTime":"0","summary":"Replimune Group's shares fell sharply after it said it is now considering how to move forward with its melanoma drug after an urgent meeting with U.S. regulators determined that an accelerated route wasn't feasible.In early trading Thursday, the shares fell 39% to $3.49.The clinical-stage biotechnology company said it is determining its next steps after concluding a type A meeting with the Food and Drug Administration on Tuesday regarding its biologics license application for RP1. RP1, also known as vusolimogene oderparepvec, is Replimune's lead product candidate based on a proprietary strain intended to fight tumors, particularly melanoma.The company said it is evaluating the feedback from the FDA to determine how to proceed since at this time a path forward under the accelerated approval pathway hasn't been determined.Chief Executive Sushil Patel said the company remains committed to working with the regulators to determine an expeditious path forward for the drug.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2568470266","title":"Replimune Group Inc - Evaluating FDA Feedback, Path Forward Undetermined","url":"https://stock-news.laohu8.com/highlight/detail?id=2568470266","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568470266?lang=en_us&edition=fundamental","pubTime":"2025-09-18 21:15","pubTimestamp":1758201300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250918:nTUAB76G6S:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2568470260","title":"Replimune Provides Update Following Type a Meeting With FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2568470260","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568470260?lang=en_us&edition=fundamental","pubTime":"2025-09-18 21:15","pubTimestamp":1758201300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250918:nTUAB76G6S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["REPL","BK4139"],"gpt_icon":0},{"id":"2568702564","title":"Press Release: Replimune Provides Update Following Type A Meeting with FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2568702564","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568702564?lang=en_us&edition=fundamental","pubTime":"2025-09-18 21:15","pubTimestamp":1758201300,"startTime":"0","endTime":"0","summary":"WOBURN, Mass., Sept. 18, 2025  -- Replimune Group, Inc. , a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the company completed a Type A meeting with the U.S. Food and Drug Administration  on September 16 to discuss the complete response letter  for the Company's Biologics License Application  for RP1 in combination with nivolumab for the treatment of advanced melanoma.The company is evaluating the feedback from the FDA provided during the meeting to determine next steps. At this time, a path forward under the accelerated approval pathway has not been determined.\"The feedback from the melanoma community, including patients and physicians, clearly highlights the unmet need in advanced melanoma and the compelling risk-benefit profile of RP1 observed in the IGNYTE trial, \" said Sushil Patel, Ph.D., CEO of Replimune. \"We remain committed to working with the FDA to determine an expeditious path forward for RP1.\"","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0390134368.USD","BK4588","BK4530","CRL","BK4121","LU0757428866.USD","BK4139","LU1815336091.USD","BK4585","REPL"],"gpt_icon":0},{"id":"2565965595","title":"Replimune Group Inc. Faces Class Action Lawsuit for Alleged Securities Fraud: Investors Urged to Take Action","url":"https://stock-news.laohu8.com/highlight/detail?id=2565965595","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565965595?lang=en_us&edition=fundamental","pubTime":"2025-09-06 05:30","pubTimestamp":1757107813,"startTime":"0","endTime":"0","summary":"A class action lawsuit has been filed against Replimune Group, Inc. on behalf of investors who suffered financial losses due to alleged securities fraud. The lawsuit pertains to activities between November 22, 2024, and July 21, 2025. Investors who incurred losses during this period are encouraged to take action and seek legal recourse. The law firm Levi & Korsinsky, known for its expertise in securities litigation, is handling the case. The firm has a strong track record of securing significant settlements for shareholders in similar high-stakes cases.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Replimune Group Inc. published the original content used to generate this news brief via ACCESS Newswire  on September 05, 2025, and is so","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250905:nNDL5SckKw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REPL","BK4139"],"gpt_icon":0},{"id":"2564804103","title":"Replimune Group Inc. Schedules FDA Meeting to Address CRL for RP1 in Advanced Melanoma Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2564804103","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564804103?lang=en_us&edition=fundamental","pubTime":"2025-09-02 20:00","pubTimestamp":1756814457,"startTime":"0","endTime":"0","summary":"Replimune Group Inc., a clinical-stage biotechnology company focused on developing innovative oncolytic immunotherapies, has announced a scheduled Type A meeting with the U.S. Food and Drug Administration . The purpose of the meeting is to discuss the complete response letter  received for the company's Biologics License Application  for RP1 in combination with nivolumab, intended for the treatment of advanced melanoma. Replimune has submitted a briefing book addressing the FDA's concerns, including prior agreements on patient population and PD-1 resistance criteria, as well as additional data analyses. The company aims to resolve these issues swiftly to secure accelerated approval for RP1, emphasizing the urgent need for new treatment options in the melanoma community. The outcome of this meeting is critical, as without accelerated approval, the continuation of the RP1 program, particularly the phase 3 confirmatory trial, may not proceed.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250902:nNDL77fbM3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","IE00B3QW5Z07.USD","LU2095319765.USD","IE00BGHQF748.EUR","BK4139","LU0314104364.USD","BK4585","IE00B64PRP62.GBP","NDAQ","REPL","BK4588","LU2210149790.SGD","LU2210150020.SGD","BK4112"],"gpt_icon":0},{"id":"2564804987","title":"Replimune Announces Type a Meeting Scheduled With FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2564804987","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564804987?lang=en_us&edition=fundamental","pubTime":"2025-09-02 20:00","pubTimestamp":1756814404,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250902:nTUA3DSPYP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2564802513","title":"Replimune Group- Briefing Book Includes Additional Analysis of Data From Bla & Addresses Comments About Phase 3 Confirmatory Trial Design","url":"https://stock-news.laohu8.com/highlight/detail?id=2564802513","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564802513?lang=en_us&edition=fundamental","pubTime":"2025-09-02 20:00","pubTimestamp":1756814404,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250902:nTUA3DSPYP:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["REPL","BK4139"],"gpt_icon":0},{"id":"2564802392","title":"Replimune Group Inc - Submits Briefing Book to FDA Addressing Crl","url":"https://stock-news.laohu8.com/highlight/detail?id=2564802392","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564802392?lang=en_us&edition=fundamental","pubTime":"2025-09-02 20:00","pubTimestamp":1756814404,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250902:nTUA3DSPYP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2564023978","title":"Replimune Group Inc - Meeting to Discuss Crl for Rp1 Bla With Nivolumab for Melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2564023978","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564023978?lang=en_us&edition=fundamental","pubTime":"2025-09-02 20:00","pubTimestamp":1756814404,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250902:nTUA3DSPYP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2561340486","title":"Replimune Group Inc. Faces Class Action Lawsuit Over Alleged Securities Fraud","url":"https://stock-news.laohu8.com/highlight/detail?id=2561340486","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561340486?lang=en_us&edition=fundamental","pubTime":"2025-08-21 02:38","pubTimestamp":1755715093,"startTime":"0","endTime":"0","summary":"Replimune Group Inc. is facing a class action lawsuit filed on behalf of investors who allege securities fraud between November 22, 2024, and July 21, 2025. The lawsuit claims that investors suffered financial losses due to the company's actions during this period. The legal proceedings have been initiated by the firm Levi & Korsinsky, known for its expertise in handling complex securities litigation. Investors affected by the alleged fraud are encouraged to take action and seek more information regarding the case.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Replimune Group Inc. published the original content used to generate this news brief via ACCESS Newswire  on August 20, 2025, and is solely responsible for the information conta","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nNDL6fhzmp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2560149530","title":"CFO Emily Luisa Hill Reports Disposal of Replimune Group Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2560149530","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560149530?lang=en_us&edition=fundamental","pubTime":"2025-08-20 08:30","pubTimestamp":1755649850,"startTime":"0","endTime":"0","summary":"Emily Luisa Hill, the Chief Financial Officer of Replimune Group Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Replimune Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 19, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nNDLlTTYc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2558655852","title":"Gene Therapy Developers Fall After Vinay Prasad Reinstated As FDA's Top Vaccine Official","url":"https://stock-news.laohu8.com/highlight/detail?id=2558655852","media":"Reuters","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558655852?lang=en_us&edition=fundamental","pubTime":"2025-08-11 17:33","pubTimestamp":1754904781,"startTime":"0","endTime":"0","summary":"BUZZ-Gene therapy developers fall after Vinay Prasad reinstated as FDA's top vaccine official** Shares of gene therapy developers fall in premarket trading, after Vinay Prasad returns as top vaccine official at U.S. FDA a little more than a week after he left the agency  ** Shares of Sarepta Therapeutics SRPT.O down 9.2% at $16.56, while Capricor CAPR.O down 10.7% at $8.1** Prasad returns as the director Center for Biologics Evaluation and Research, which oversees costly and complicated biologic drugs, including vaccines and gene therapies at FDA** The news could be taken with \"caution on how long, if at all, Prasad will actually be staying\", Jefferies analysts say, adding that his reinstatement could impact vaccine makers and gene therapy developers \"towards more evidence-based approach, which could be a double-edge sword in the near term\"** A number of controversial decisions by the FDA regarding Sarepta's muscular disorder gene therapy, Elevidys, contributed to Prasad's departure la","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8d7b187999f3d5b6d93262f3a7df1856","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250811:nL4N3U30H1:1","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gene Therapy Developers Fall After Vinay Prasad Reinstated As FDA's Top Vaccine Official","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","IE00BFTCPJ56.SGD","SRPT","IE00BJJMRZ35.SGD","CAPR","REPL","BK4585","IE0002141913.USD","IE00B2B36J28.USD","BK4139","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2557598612","title":"Replimune Group Inc reports results for the quarter ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2557598612","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557598612?lang=en_us&edition=fundamental","pubTime":"2025-08-08 01:31","pubTimestamp":1754587867,"startTime":"0","endTime":"0","summary":"Replimune Group Inc reports results for the quarter ended June 30 - Earnings SummaryReplimune Group Inc REPL.OQ reported a quarterly adjusted loss of 95 cents per share for the quarter ended June 30, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nL8N3TZ2RP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REPL"],"gpt_icon":0},{"id":"2557568732","title":"Replimune Group Q1 EPS $(0.95) Misses $(0.84) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2557568732","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557568732?lang=en_us&edition=fundamental","pubTime":"2025-08-07 20:12","pubTimestamp":1754568742,"startTime":"0","endTime":"0","summary":"Replimune Group (NASDAQ:REPL) reported quarterly losses of $(0.95) per share which missed the analyst consensus estimate of $(0.84) by 12.96 percent. This is a 21.79 percent decrease over losses of $(0.78) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"4159205b16c8b64f62923b1eb2d3a0b7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/46959514/replimune-group-q1-eps-0-95-misses-0-84-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REPL"],"gpt_icon":0},{"id":"2557946563","title":"Replimune Group Q1 Net Income USD -86.693 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2557946563","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557946563?lang=en_us&edition=fundamental","pubTime":"2025-08-07 20:11","pubTimestamp":1754568700,"startTime":"0","endTime":"0","summary":"Aug 07 (Reuters) - Replimune Group Q1 operating expenses USD 90.422 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 07-AUG-202512:00:49 GMT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"4159205b16c8b64f62923b1eb2d3a0b7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nRSD5h202q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2557756834","title":"Replimune Group Q1 Operating Income USD -90.422 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2557756834","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557756834?lang=en_us&edition=fundamental","pubTime":"2025-08-07 20:00","pubTimestamp":1754568003,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"4159205b16c8b64f62923b1eb2d3a0b7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nPLX8FDBC6:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["REPL","BK4139"],"gpt_icon":0},{"id":"2557531568","title":"Replimune Group Q1 Cash & Investments USD 403.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2557531568","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557531568?lang=en_us&edition=fundamental","pubTime":"2025-08-07 20:00","pubTimestamp":1754568003,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"4159205b16c8b64f62923b1eb2d3a0b7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nPLX8FDBC6:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["REPL","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":100,"code":"91000000","status":"200"}]}}